
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia is attractive because its integrated patient intake, payments, and engagement platform is deeply embedded in provider workflows, creating switching costs while monetizing a scaled network that serves over 4,400 healthcare providers and ~170M patient visits. In 2Q27, revenue of $129.5M rose 10% year over year, adjusted EBITDA reached $32.9M, and the 25.4% margin improved sharply on restructuring and disciplined expense controls, while cash of $74.6M exceeded debt of $61.2M after $23.5M of principal paydown. The bullish case is further supported by 4,744 provider clients, 6.2% client growth, strong network solutions momentum, and early AccessOne progress that could expand patient payment opportunities and lift growth as management reinvests in the core business.
Bears say
Phreesia is facing a muted growth profile as management held FY27 revenue guidance at $515 million, implying 7% year-over-year growth, yet that still translates into less than 1% organic growth and a reduced subscription revenue forecast from +4% to (4%). The outlook is further pressured by a delayed AccessOne ramp into FY28, conservative assumptions for AHSC additions and payment solutions, and execution risk that could weaken free cash flow and debt repayment capacity in the company’s downside case. Although adjusted EBITDA guidance of $125 million to $135 million was reiterated, heavier hiring for Provider Connect and rising AI costs, combined with competition from Epic and Oracle and potential FDA-related ad spending pressure, support a negative fundamental view.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Phreesia Inc (PHR) Forecast
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares